Literature DB >> 19917274

Verification of complete bisulfite modification using Calponin-specific primer sets.

Ruethairat Sriraksa1, Patimaporn Chaopatchayakul, Patcharee Jearanaikoon, Chanvit Leelayuwat, Temduang Limpaiboon.   

Abstract

OBJECTIVES: To verify complete bisulfite modification. DESIGN AND METHODS: Bisulfite modified DNA was screened by PCR with Calponin-specific primer sets prior to detecting methylation status of 14-3-3sigma by methylation-specific PCR.
RESULTS: False positive methylation was obtained from incomplete bisulfite modification. The lower detection limit of wild type Calponin-specific primer is approximately 0.375 ng of unmodified DNA.
CONCLUSIONS: Verification of complete bisulfite modification by Calponin-specific primer sets can reduce misinterpretation of methylation. Copyright 2009 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19917274     DOI: 10.1016/j.clinbiochem.2009.11.005

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  7 in total

1.  DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma.

Authors:  Rattaya Amornpisutt; Siriporn Proungvitaya; Patcharee Jearanaikoon; Temduang Limpaiboon
Journal:  Tumour Biol       Date:  2015-02-05

2.  Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts.

Authors:  F Guffanti; M F Alvisi; A Anastasia; F Ricci; M Chiappa; A Llop-Guevara; V Serra; R Fruscio; A Degasperi; S Nik-Zainal; M R Bani; M Lupia; R Giavazzi; E Rulli; G Damia
Journal:  Br J Cancer       Date:  2021-11-03       Impact factor: 7.640

3.  CpG-island methylation study of liver fluke-related cholangiocarcinoma.

Authors:  R Sriraksa; C Zeller; M A El-Bahrawy; W Dai; J Daduang; P Jearanaikoon; S Chau-In; R Brown; T Limpaiboon
Journal:  Br J Cancer       Date:  2011-03-29       Impact factor: 7.640

4.  Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance.

Authors:  Sabrina Grasse; Matthias Lienhard; Steffen Frese; Martin Kerick; Anne Steinbach; Christina Grimm; Michelle Hussong; Jana Rolff; Michael Becker; Felix Dreher; Uwe Schirmer; Stefan Boerno; Anna Ramisch; Gunda Leschber; Bernd Timmermann; Christian Grohé; Heike Lüders; Martin Vingron; Iduna Fichtner; Sebastian Klein; Margarete Odenthal; Reinhard Büttner; Hans Lehrach; Holger Sültmann; Ralf Herwig; Michal R Schweiger
Journal:  Genome Med       Date:  2018-07-20       Impact factor: 11.117

5.  Promoter hypermethylation of early B cell factor 1 (EBF1) is associated with cholangiocarcinoma progression.

Authors:  Napat Armartmuntree; Apinya Jusakul; Chadamas Sakonsinsiri; Watcharin Loilome; Somchai Pinlaor; Piti Ungarreevittaya; Chern Han Yong; Anchalee Techasen; Kanokwan Imtawil; Ratthaphol Kraiklang; Nattawan Suwannakul; Waleeporn Kaewlert; Timpika Chaiprasert; Raynoo Thanan; Mariko Murata
Journal:  J Cancer       Date:  2021-03-05       Impact factor: 4.207

6.  Reference Materials for Calibration of Analytical Biases in Quantification of DNA Methylation.

Authors:  Hannah Yu; Yoonsoo Hahn; Inchul Yang
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

7.  Transcriptional and epigenetic regulation of KIF14 overexpression in ovarian cancer.

Authors:  Brigitte L Thériault; Halesha D Basavarajappa; Harvey Lim; Sanja Pajovic; Brenda L Gallie; Timothy W Corson
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.